Weigao Group
山东威高集团医用高分子制品股份有限公司（「本公司」）及其附属公司（统称「本集团」）主要从事研发及开发、生产及销售一次性医疗器械。. 本集团提供不同种类产品，包括：i）耗材（ …
Enterprise Introduction - Weigao Group
Shandong Weigao Group Medical Polymer Company Limited (the “Company”) and its subsidiaries (together the “Group”) is principally engaged in the research and development, production and …
Investor Relations - Weigao Group
2024/10/16 UPDATED INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024. 2024/10/16 POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 16 …
Product Category - Weigao Group
Product Category. Infusion set with burette…. Packing Sealing Machine. MSL.NC Fully Automatic Ve…. MSG.BSDZ Fully Automatic …. Disposable Pressure Exten…. Single Use Venipuncture …
Investor Relations - Weigao Group
2023/04/27 ANNUAL REPORT 2022. 2023/04/27 An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may …
Investor Relations - Weigao Group
2024/04/29 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023. ANNUAL REPORT 2023. 2024/04/29 PROPOSED AMENDMENTS TO THE ARTICLES OF …
BOARD OF DIRECTORS - Enterprise Management - Weigao Group
From December 2022 to March 2024, Ms. Yan was a director of Shandong Weigao Orthopaedic Device Company Limited, a subsidiary of the Company (Stock code: 688161.SH).Prior to …
Weigao Holding to (i) extend the agreement term for two years to 31 December 2023; and (ii) propose new annual caps of RMB500 million for each of the years ending 31 December 2022 …
The annual general meeting (“AGM”) of Shandong Weigao Group Medical Polymer Company Limited (the “Company”) were held on 24 May 2021. The Board of the Company (the “Board”) …
SUMMARYFor the six months ended 30 June 2021 (the “Period”), the unaudited revenue of Shandong Weigao Group Medical Polymer Company Limited (the “Company”) and its …